Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone treatment reduced hair growth and androgen levels in hirsute women, but the overall effectiveness was just adequate.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Testosterone replacement therapy, especially intramuscular, raises PSA levels, but no overall link between PSA and testosterone was found except in non-BPH patients.

5α-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT levels.

Lowering certain hormone levels improves treatment for hair loss in young men.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Hair loss and excessive growth treated with various options, including new laser technology.

Traditional Chinese Medicine, combined with antiandrogen therapy, could improve treatment and reduce side effects for genetic hair loss.

The woman likely has a hormonal imbalance causing excessive hair growth.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Finasteride is effective for male hair loss, but it may cause fertility issues, mental health problems, and rarely, breast growth. Regular health checks can reduce the risk of prostate cancer. Patient understanding and involvement in treatment is important.

Testosterone therapy in transgender individuals can increase the risk of erythrocytosis.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Higher testosterone and dehydroepiandrosterone sulphate levels may help diagnose meibomian gland dysfunction.

A testosterone-induced hair loss model in mice was successfully created for future research and treatment testing.

The document recommends a multidisciplinary approach and experience sharing to advance facial feminization surgery as a medical field.

Finasteride reduces hair growth and is safe for women with excessive hair.

Hirsutism is managed by assessing testosterone levels and using oral contraceptives, with ethical considerations on treatment access.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Hormonal treatments can effectively improve hidradenitis suppurativa symptoms.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Estrogen may help improve COVID-19 outcomes, especially in women.

High androgen levels can cause excessive hair growth and may indicate serious health issues, including heart disease and fertility problems.